Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Receivables (2023 - 2025)

Ardent Health has reported Receivables over the past 3 years, most recently at $707.2 million for Q4 2025.

  • Quarterly results put Receivables at $707.2 million for Q4 2025, down 8.5% from a year ago — trailing twelve months through Dec 2025 was $707.2 million (down 8.5% YoY), and the annual figure for FY2025 was $707.2 million, down 8.5%.
  • Receivables for Q4 2025 was $707.2 million at Ardent Health, down from $760.3 million in the prior quarter.
  • Over the last five years, Receivables for ARDT hit a ceiling of $821.6 million in Q2 2025 and a floor of $707.2 million in Q4 2025.
  • Median Receivables over the past 3 years was $766.6 million (2024), compared with a mean of $773.6 million.
  • Peak annual rise in Receivables hit 9.18% in 2025, while the deepest fall reached 8.5% in 2025.
  • Ardent Health's Receivables stood at $809.9 million in 2023, then dropped by 4.56% to $772.9 million in 2024, then fell by 8.5% to $707.2 million in 2025.
  • The last three reported values for Receivables were $707.2 million (Q4 2025), $760.3 million (Q3 2025), and $821.6 million (Q2 2025) per Business Quant data.